{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:16:11Z","timestamp":1791573371479,"version":"4.3.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.hpb.2018.03.008","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T09:25:12Z","timestamp":1524734712000},"page":"841-847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Outcome of neoadjuvant chemotherapy in \u201clocally advanced\/borderline resectable\u201d gallbladder cancer: the need to define indications"],"prefix":"10.1016","volume":"20","author":[{"given":"Vikram A.","family":"Chaudhari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Ostwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha","family":"Patkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Toshniwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin S.","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh V.","family":"Shrikhande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2018.03.008_bib1","first-page":"349","article-title":"Epidemiology and molecular pathology of gallbladder cancer","volume":"51","author":"Lazcano-Ponce","year":"2001","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.hpb.2018.03.008_bib2","first-page":"537","article-title":"Towards an oncological resection of gall bladder cancer","volume":"20","author":"Boerma","year":"1994","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2018.03.008_bib3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/01.COC.0000018037.59196.67","article-title":"Gemcitabine and cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder","volume":"26","author":"Malik","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.hpb.2018.03.008_bib4","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2018.03.008_bib5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/s12885-015-1617-y","article-title":"Adjuvant therapy in the treatment of gallbladder cancer: a meta-analysis","volume":"15","author":"Ma","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.hpb.2018.03.008_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s13193-015-0377-0","article-title":"Resection after neoadjuvant chemotherapy in advanced carcinoma of the gallbladder: a retrospective study","volume":"6","author":"Selvakumar","year":"2015","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.hpb.2018.03.008_bib7","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2217\/fon.14.308","article-title":"Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer","volume":"11","author":"Sirohi","year":"2015","journal-title":"Future Oncol"},{"key":"10.1016\/j.hpb.2018.03.008_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.hpb.2018.03.008_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/bmj.2.5402.177","article-title":"Human experimentation. Code of ethics of the world medical association. Declaration of Helsinki","volume":"2","author":"Rickham","year":"1964","journal-title":"Br Med J"},{"key":"10.1016\/j.hpb.2018.03.008_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.03.008_bib11","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hpb.2018.03.008_bib12","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1245\/s10434-008-0189-3","article-title":"Analysis of the extent of resection for adenocarcinoma of the gallbladder","volume":"16","author":"D'Angelica","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2018.03.008_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.sla.0000154118.07704.ef","article-title":"An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center","volume":"241","author":"Dixon","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2018.03.008_bib14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1245\/s10434-006-9097-6","article-title":"Gallbladder cancer: defining the indications for primary radical resection and radical re-resection","volume":"14","author":"Foster","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2018.03.008_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1245\/s10434-012-2312-8","article-title":"Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study","volume":"20","author":"Kato","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2018.03.008_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/13651820701867794","article-title":"Revision surgery for incidental gallbladder cancer: factors influencing operability and further evidence for T1b tumours","volume":"10","author":"Shukla","year":"2008","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2018.03.008_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7869\/tg.162","article-title":"Management of incidentally detected gallbladder carcinomas in a high prevalence area of gall bladder cancer","volume":"35","author":"Kallianpur","year":"2015","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.hpb.2018.03.008_bib18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00280-009-1069-7","article-title":"Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial","volume":"65","author":"Jang","year":"2010","journal-title":"Canc Chemother Pharmacol"},{"key":"10.1016\/j.hpb.2018.03.008_bib19","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/sj.bjc.6604628","article-title":"Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study","volume":"99","author":"Andre","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.hpb.2018.03.008_bib20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.5009\/gnl.2013.7.5.594","article-title":"A\u00a0multicenter Phase II trial of gemcitabine plus oxaliplatin in unresectable gallbladder cancer","volume":"7","author":"Woo","year":"2013","journal-title":"Gut Liver"},{"key":"10.1016\/j.hpb.2018.03.008_bib21","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jamcollsurg.2016.12.058","article-title":"Systemic chemotherapy combined with resection for locally advanced gallbladder carcinoma: surgical and survival outcomes","volume":"224","author":"Creasy","year":"2017","journal-title":"J\u00a0Am Coll Surg"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X18307834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X18307834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:16:01Z","timestamp":1761264961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X18307834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1365182X18307834"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2018.03.008","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome of neoadjuvant chemotherapy in \u201clocally advanced\/borderline resectable\u201d gallbladder cancer: the need to define indications","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2018.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}